Community Care Cooperative has named Jenny Carney as its new Chief Operating Officer

BOSTON–(BUSINESS WIRE)–Jenny Carney has been named the chief operating officer for Community Care Cooperative (C3), a national, non-profit Accountable Care Organization (ACO) that is governed by Federally Qualified Health Centers (FQHCs) to improve the health and wellness of its members throughout the United States.




Ms. Carney joins C3 from Milliman, where she was serving as a senior healthcare consultant in integrated health systems, health plans, and negotiation contract support for its Medicare Shared Savings Program (MSSP), Accountable Care Organization (ACO) REACH, Medicare Advantage, Medicaid, and commercial lines of business.

Prior to joining Milliman, Jenny served as the vice president of Finance and Analytics for the Beth Israel Lahey Health Performance Network, and also worked in the operational integration of three legacy organizations following the merger between Beth Israel and Lahey Health. Jenny has also worked at Network Health, where she led its medical economics and performance analytics team.

She earned her undergraduate degree in mathematics from St. Michael’s College, and her master’s degree in public health practice from the University of Massachusetts at Amherst.

“Jenny’s knowledge and successful leadership experience adds significant value as we continue to grow,” says C3 President and Chief Executive Officer Christina Severin.

ABOUT COMMUNITY CARE COOPERATIVE (C3)

Community Care Cooperative (C3) is a 501(c)(3) national non-profit organization created and governed by Federally Qualified Health Centers (FQHCs) to transform the health and wellness of the people they serve. Formed in 2016 as a MassHealth Accountable Care Organization (ACO) that uses the proven best practices of ACOs throughout the country, C3 is the only ACO founded and governed by Federally Qualified Health Centers (FQHCs) and exclusively focused on advancing integrated and coordinated community-based care. Since its inception, C3 has expanded its services and grown as leader and advocate for community health centers. Community Technology Cooperative (CTC) is a subsidiary of C3 formed to help improve health and equity for under-resourced communities through technology. Comprised of FQHCs throughout Massachusetts, CTC is focused on transitioning our existing Electronic Health Records (EHR) systems to Epic. Community Pharmacy Cooperative (CPC) operates on-site pharmacies, improves 340B revenue and compliance, and provides clinical services for FQHCs and their patients.

Contacts

Paul Fleming
Marketing and Communications Manager
978-683-0358
pfleming@c3aco.org
https://www.communitycarecooperative.org/

Staff

Recent Posts

Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

8 minutes ago

Functional Brands Inc. Launches Kirkman’s(R) Skin, Beauty & Anti-Aging Bundle: A Science-Backed Approach to Radiant, Resilient Skin

Comprehensive Formula Featuring Reduced Glutathione, Zinc Cream, Biotin, and Grapefruit Seed ExtractLake Oswego, Oregon--(Newsfile Corp.…

8 minutes ago

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

1 hour ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

2 hours ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

2 hours ago